• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国多发性硬化症患病率的修订估计值。

Revised estimate of the prevalence of multiple sclerosis in the United States.

作者信息

Anderson D W, Ellenberg J H, Leventhal C M, Reingold S C, Rodriguez M, Silberberg D H

机构信息

Biometry and Field Studies Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.

出版信息

Ann Neurol. 1992 Mar;31(3):333-6. doi: 10.1002/ana.410310317.

DOI:10.1002/ana.410310317
PMID:1637140
Abstract

Using three adjustments, we have revised a 1976 prevalence count for multiple sclerosis in the United States. The adjustments were made to data from a US national survey; they used 1990 population projections from the US Bureau of the Census, and results of investigations conducted in Weld and Larimer Countries, Colorado, and Olmsted County, Minnesota. It is estimated that approximately 250,000 to 350,000 persons in the United States in 1990 had physician-diagnosed multiple sclerosis.

摘要

通过三项调整,我们修正了1976年美国多发性硬化症的患病率统计数据。这些调整是针对一项美国全国性调查的数据进行的;使用了美国人口普查局1990年的人口预测数据,以及在科罗拉多州韦尔德县和拉里默县、明尼苏达州奥尔姆斯特德县开展的调查结果。据估计,1990年美国约有25万至35万人被医生诊断患有多发性硬化症。

相似文献

1
Revised estimate of the prevalence of multiple sclerosis in the United States.美国多发性硬化症患病率的修订估计值。
Ann Neurol. 1992 Mar;31(3):333-6. doi: 10.1002/ana.410310317.
2
Prevalence of the chronic sinusitis diagnosis in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县慢性鼻窦炎诊断的患病率。
Arch Otolaryngol Head Neck Surg. 2004 Mar;130(3):320-3. doi: 10.1001/archotol.130.3.320.
3
Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.奥姆斯特德县人群中多发性硬化症震颤的患病率及相关残疾情况。
Mov Disord. 2004 Dec;19(12):1482-5. doi: 10.1002/mds.20227.
4
The incidence and prevalence of reported multiple sclerosis.
Ann Neurol. 1981 Nov;10(5):420-8. doi: 10.1002/ana.410100504.
5
Contributions to neurology from records linkage in Olmsted County, Minnesota.明尼苏达州奥尔姆斯特德县通过记录链接对神经学的贡献。
Adv Neurol. 1978;19:93-105.
6
How common are the "common" neurologic disorders?“常见”的神经系统疾病有多常见?
Neurology. 2007 Jan 30;68(5):326-37. doi: 10.1212/01.wnl.0000252807.38124.a3.
7
Incidence, associations, and evaluation of sixth nerve palsy using a population-based method.采用基于人群的方法对展神经麻痹的发病率、相关性及评估
Ophthalmology. 2004 Feb;111(2):369-75. doi: 10.1016/j.ophtha.2003.05.024.
8
Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking.美国社区中自我报告的直肠出血:患病率、危险因素及医疗寻求情况
Am J Gastroenterol. 1998 Nov;93(11):2179-83. doi: 10.1111/j.1572-0241.1998.00530.x.
9
Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey.身体残疾者对补充和替代医学从业者的使用情况:来自美国全国调查的估计
Disabil Rehabil. 2006 Apr 30;28(8):505-13. doi: 10.1080/09638280500212062.
10
Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999.1991 - 1999年美国成年人自我报告的多种心血管疾病风险因素趋势
Arch Intern Med. 2004 Jan 26;164(2):181-8. doi: 10.1001/archinte.164.2.181.

引用本文的文献

1
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS.一项 1b 期、开放标签的研究,旨在评估假定的髓鞘修复剂左甲状腺素在多发性硬化症患者中的安全性和耐受性。
Neurotherapeutics. 2023 Sep;20(5):1263-1274. doi: 10.1007/s13311-023-01402-3. Epub 2023 Jul 17.
2
Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.多发性硬化症图谱:进展性多发性硬化症脑损伤阶段的分子图谱
Netw Syst Med. 2020 Aug 27;3(1):122-129. doi: 10.1089/nsm.2020.0006. eCollection 2020.
3
Are virus infections triggers for autoimmune disease?
病毒感染是自身免疫性疾病的触发因素吗?
Clin Microbiol Newsl. 2002 May 15;24(10):73-76. doi: 10.1016/S0196-4399(02)80019-8. Epub 2002 Jul 25.
4
Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.阿拉伯世界多发性硬化症患者认知评估的系统评价。
Neuropsychol Rev. 2019 Sep;29(3):259-269. doi: 10.1007/s11065-019-09408-5. Epub 2019 May 17.
5
The prevalence of MS in the United States: A population-based estimate using health claims data.美国多发性硬化症的患病率:基于健康索赔数据的人群估计。
Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.
6
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.一种新的方法来估计美国神经系统疾病的患病率:以多发性硬化症为例。
Neurology. 2019 Mar 5;92(10):469-480. doi: 10.1212/WNL.0000000000007044. Epub 2019 Feb 15.
7
Multidisciplinary Management of a Patient With Multiple Sclerosis: Part 1. Neurologists' and Physiatrists' Perspectives.一名多发性硬化症患者的多学科管理:第1部分。神经科医生和物理治疗师的观点。
Fed Pract. 2015 Apr;32(Suppl 3):14S-17S.
8
Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β.颗粒酶B激活蛋白酶激活受体-1会导致神经毒性,而白细胞介素-1β会加剧这种毒性。
J Neuroinflammation. 2017 Jun 27;14(1):131. doi: 10.1186/s12974-017-0901-y.
9
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.多发性硬化症中的精准医学:炎症和反应性星形胶质细胞PET成像的未来。
Front Mol Neurosci. 2016 Sep 15;9:85. doi: 10.3389/fnmol.2016.00085. eCollection 2016.
10
Ratiometric analysis of in vivo retinal layer thicknesses in multiple sclerosis.多发性硬化症体内视网膜层厚度的比率分析。
J Biomed Opt. 2016 Sep 1;21(9):95001. doi: 10.1117/1.JBO.21.9.095001.